We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Statins Reduce Cardiovascular Risk Following Irradiation

By MedImaging International staff writers
Posted on 15 Aug 2019
Print article
Cancer patients taking statins following radiation therapy (RT) of the upper body had significantly reduced risk of stroke and other cardiovascular complications, according to a new study.

Researchers at McGill University (Montreal, Canada), Walter Reed National Military Medical Centre (Washington DC, USA), and other institutions conducted a retrospective cohort study involving 5,718 cardiac patients with thorax and head or neck cancer who underwent RT between 2000 and 2011; of these, 1,552 did not use statins, while 4,166 did. The primary outcome was a composite of transient ischemic attack (TIA), fatal or nonfatal stroke, or fatal or nonfatal myocardial infarction (MI).

After adjusting for age, sex, prior history of stroke/TIA or MI, diabetes mellitus, dyslipidemia, atrial fibrillation (AF), chronic kidney disease (CKD), heart failure (HF), and hypertension, statin use following RT was associated with a nonsignificant 15% relative risk reduction, but a strong trend toward reducing the primary outcome, and especially with a significant reduction of 32% for the outcome of stroke alone. The study was published on July 2, 2019, in Journal of the American Heart Association.

“Statins decrease cholesterol levels and have anti-inflammatory properties. Statins are protective in patients with heart disease, previous strokes, and with high cholesterol levels,” said senior author Negar Mousavi, MD, MHSc, of McGill University Health Center. “Our study demonstrated that statin therapy could be favorable even with the competing risks of cancer and cancer-related mortality in patients who received radiation therapy.”

While RT is an effective treatment for many different types of cancers, the net clinical benefit of RT is mitigated by an increased risk of cardiovascular and cerebrovascular diseases, including ischemic stroke, TIA, carotid stenosis, and MI. The mechanism of action is incompletely understood, but appears to be independent of conventional vascular risk factors, with data suggesting a key role for inflammation and accelerated atherosclerosis. The pattern of plaque generation within affected arteries appears to be distinct from that generated solely by traditional atherosclerosis.

Related Links:
McGill University
Walter Reed National Military Medical Centre

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Needle Guide
Ultra-Pro II
New
Wireless Handheld Ultrasound System
TE Air
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.